氢化可的松联合维生素C和维生素B1治疗脓毒症患者的疗效:一项Meta分析
该Meta分析检索CNKI、SinoMed、维普、万方、PubMed、Cochrane图书馆和Embase自建库至2021年1月的RCT,纳入6项研究共816例患者(试验组411例、对照组405例),评估氢化可的松联合维生素C和维生素B1对脓毒症或脓毒性休克患者的疗效。结果显示试验组血管活性药物使用时间显著短于对照组(MD=-24.02,95%CI -32.36至-15.68,P<0.000 01),但SOFA评分、病死率、新发AKI、ICU住院时间和住院时间两组间无显著差异。漏斗图提示发表偏倚较小。作者认为受纳入研究数量和质量限制,仍需大规模、多中心、盲法RCT验证。
要点
- 纳入6项RCT共816例脓毒症或脓毒性休克患者,试验组411例、对照组405例。
- 试验组血管活性药物使用时间较对照组显著缩短(MD=-24.02,95%CI -32.36至-15.68,P<0.000 01)。
- 两组SOFA评分无显著差异(MD=-0.14,95%CI -1.15至0.87,P=0.79)。
- 两组病死率无显著差异(RR=0.99,95%CI 0.81至1.21,P=0.92)。
- 新发AKI(RR=1.10,95%CI 0.42至2.87,P=0.84)、ICU住院时间(MD=1.33,95%CI -2.22至4.89,P=0.46)和住院时间(MD=1.02,95%CI -0.66至2.69,P=0.23)两组间无显著差异。
适用人群与场景
- 脓毒症或脓毒性休克患者;试验组在常规治疗基础上静脉注射氢化可的松、维生素B1和维生素C,对照组在常规治疗基础上给予常规治疗或安慰剂/氢化可的松/氢化可的松+维生素B1。
研究设计与关键结果
- 研究类型:Meta分析,纳入6项RCT,共816例患者,试验组411例、对照组405例。
- 试验组血管活性药物使用时间较对照组显著缩短(MD=-24.02,95%CI -32.36至-15.68,P<0.000 01)。
- 两组SOFA评分无显著差异(MD=-0.14,95%CI -1.15至0.87,P=0.79)。
- 两组病死率无显著差异(RR=0.99,95%CI 0.81至1.21,P=0.92)。
- 两组新发AKI无显著差异(RR=1.10,95%CI 0.42至2.87,P=0.84)。
- 两组ICU住院时间无显著差异(MD=1.33,95%CI -2.22至4.89,P=0.46)。
- 两组住院时间无显著差异(MD=1.02,95%CI -0.66至2.69,P=0.23)。
- 漏斗图显示多数点对称并呈倒漏斗形,提示研究间发表偏倚较小,该Meta分析无显著发表偏倚。
证据类型、等级与局限
- 证据类型:Meta分析(纳入6项RCT)。
- 局限:受纳入研究数量和质量限制,仍需大规模、多中心、盲法RCT进一步验证。
对床旁实践的改变
- 作者认为氢化可的松联合维生素C和维生素B1可缩短脓毒症或脓毒性休克患者血管活性药物使用时间。
- 作者认为该方案不能有效降低SOFA评分、病死率、新发AKI、ICU住院时间和住院时间。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To systematically evaluate the effect of hydrocortisone combined with vitamin C and vitamin B1 on the efficacy of patients with sepsis or septic shock.
METHODS: Databases including CNKI, Sino Med, VIP, Wanfang, PubMed, the Cochrane Library, and Embase were searched from inception to January 2021 for the randomized controlled trial (RCT) about hydrocortisone combined with vitamin C and vitamin B1 to treat sepsis or septic shock. The experimental group was given intravenous injection of hydrocortisone, vitamin B1 and vitamin C based on conventional treatment; the control group was given conventional treatment or placebo/hydrocortisone/hydrocortisone+vitamin B1 based on conventional treatment. Outcome indicators included sequential organ failure assessment (SOFA), mortality, the duration of vasoactive drugs, new acute kidney injury (AKI) patients, length of stay in intensive care unit (ICU) and in hospital. Two researchers independently screened the literature, extracted data, and evaluated the risk of bias in the included studies. RevMan 5.3 software was then used to perform Meta-analysis. Funnel plot was used to test publication bias.
RESULTS: A total of 6 articles involving 816 patients were included, with 411 patients in the experimental group and 405 patients in the control group. The Meta-analysis results showed that the duration of vasoactive drugs in the experimental group was significantly shorter than that in the control group [mean difference (MD) = -24.02, 95% confidence interval (95%CI) was -32.36 to -15.68, P < 0.000 01]. However, there were no significant differences in SOFA, mortality, new AKI patients, the length of ICU stay and hospital stay between the two groups [SOFA: MD = -0.14, 95%CI was -1.15 to 0.87, P = 0.79; mortality: relative risk (RR) = 0.99, 95%CI was 0.81 to 1.21, P = 0.92; new AKI patients: RR = 1.10, 95%CI was 0.42 to 2.87, P = 0.84; length of ICU stay: MD = 1.33, 95%CI was -2.22 to 4.89, P = 0.46; length of hospital stay: MD = 1.02, 95%CI was -0.66 to 2.69, P = 0.23]. The funnel plot showed that most of the points were symmetrical and showed an inverted funnel shape, suggesting that the publication bias among the studies was small. There was no significant publication bias on this Meta-analysis.
CONCLUSIONS: Hydrocortisone combined with vitamin C and vitamin B1 can shorten the duration of vasoactive drugs in patients with sepsis or septic shock, but it cannot effectively reduce the SOFA score, mortality, new AKI patients, length of stay in ICU and in hospital. Limited by the number and quality of the included studies, further large-scale, multi-center, blinded, RCT are still needed for verification.
参考来源
- Chang C, Luo K, Zhu H, et al. [Therapeutic effect of hydrocortisone combined with vitamin C and vitamin B1 on patients with sepsis: a Meta-analysis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34839858. doi:10.3760/cma.j.cn121430-20210728-01101
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。